Edward M. Kaye M.D., CEO at Stoke Therapeutics, Inc. (STOK), sold 25,000 shares at $60.00 ($1.5M) on 2020-12-18, disclosed to the SEC on 2020-12-18.
Open-market sale of $1.5M STOK by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.00 | 19,806 | $1.2M | 79.2% |
| 2 | $60.00 | 5,194 | $312K | 20.8% |
| Total | $60.00 avg | 25,000 | $1.5M | 100% |
| Filing → |
| STOK | SELL | 2025-12-10 | $702K | — | Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |